ENTRY       D00248                      Drug
NAME        Busulfan (JP18/USP/INN);
            Myleran (TN)
PRODUCT     BUSULFEX (Otsuka America Pharmaceutical)
            MYLERAN (Waylis Therapeutics LLC)
            MYLERAN (Woodward Pharma Services LLC)
  GENERIC   BUSULFAN (Accord Healthcare)
            BUSULFAN (Amneal Pharmaceuticals LLC)
            BUSULFAN (Armas Pharmaceuticals)
            BUSULFAN (CELLTRION USA)
            BUSULFAN (Hospira)
            BUSULFAN (Meitheal Pharmaceuticals)
            BUSULFAN (Meitheal Pharmaceuticals)
            BUSULFAN (Mylan Institutional LLC)
            BUSULFAN (Nexus Pharmaceuticals LLC)
            BUSULFAN (Pharmascience)
            BUSULFAN (Sagent Pharmaceuticals)
FORMULA     C6H14O6S2
EXACT_MASS  246.0232
MOL_WEIGHT  246.3018
CLASS       Antineoplastic
             DG01677  Alkylating agent
              DG01721  Methanesulfonate derivative
REMARK      Same as: C06862
            Therapeutic category: 4213
            ATC code: L01AB01
            Product: D00248<JP/US>
EFFICACY    Antineoplastic, Alkylating agent, Immunosuppressant
  DISEASE   Chronic myelogenous (myeloid, myelocytic, granulocytic) leukemia [DS:H00004]
COMMENT     Busulfan is clearly less effective in patients with chronic myelogenous leukemia who lack the Philadelphia (Ph1) chromosome.
TARGET      DNA
INTERACTION  
STR_MAP     map07040  Antineoplastics - alkylating agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01A ALKYLATING AGENTS
                L01AB Alkyl sulfonates
                 L01AB01 Busulfan
                  D00248  Busulfan (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Alkylating Agents
               Busulfan
                D00248  Busulfan (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               421  Alkylating agents
                4213  Sulfonate esters
                 D00248  Busulfan (JP18/USP/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01677  Alkylating agent
               DG01721  Methanesulfonate derivative
                D00248  Busulfan
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00248  Busulfan
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00248
DBLINKS     CAS: 55-98-1
            PubChem: 7847314
            ChEBI: 28901
            LigandBox: D00248
            NIKKAJI: J2.316G
ATOM        14
            1   S4a S    16.2149  -21.9100
            2   O2a O    17.4273  -22.6100
            3   C1b C    18.6397  -21.9100
            4   C1b C    19.8522  -22.6100
            5   C1b C    21.0646  -21.9100
            6   C1b C    22.2770  -22.6100
            7   O2a O    23.4895  -21.9100
            8   S4a S    24.7019  -22.6100
            9   C1a C    15.0024  -21.2100
            10  O3c O    16.9209  -20.6867
            11  O3c O    15.5214  -23.1115
            12  C1a C    25.9144  -23.3100
            13  O3c O    25.4243  -21.4059
            14  O3c O    23.9838  -23.8069
BOND        13
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     6   7 1
            7     7   8 1
            8     1   9 1
            9     1  10 2
            10    1  11 2
            11    8  12 1
            12    8  13 2
            13    8  14 2
///
